Albireo Pharma: Q1 Earnings Insights Albireo Pharma (NASDAQ:ALBO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Albireo Pharma missed estimated earnings by 18.38%, reporting an EPS of $-2.19 versus an estimate of $-1.85. Benzinga · May 16, 2022
Albireo Pharma's Earnings Outlook Albireo Pharma (NASDAQ:ALBO) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Albireo Pharma will report an earnings per share (EPS) of $-1.85. Benzinga · May 13, 2022
Albireo Pharma Earnings Perspective: Return On Capital Employed Benzinga Pro data, Albireo Pharma (NASDAQ:ALBO) reported Q4 sales of $32.52 million. Earnings fell to a loss of $10.96 million, resulting in a 119.2% decrease from last quarter. Benzinga · Mar 3, 2022
Recap: Albireo Pharma Q4 Earnings Albireo Pharma (NASDAQ:ALBO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Benzinga · Mar 1, 2022